J C Gillis
Overview
Explore the profile of J C Gillis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
331
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spencer C, Goa K, Gillis J
Drugs
. 1998 Jan;
54(6):925-75.
PMID: 9421697
Tacrolimus (FK 506) has been evaluated as immunosuppressive therapy in patients with a variety of solid organ and other transplants. Extensive data have now confirmed its efficacy as primary or...
2.
Gillis J, Markham A
Drugs
. 1998 Jan;
54(6):885-902.
PMID: 9421695
Irbesartan inhibits the activity of angiotensin II (AII) via specific, selective noncompetitive antagonism of the AII receptor subtype 1 (AT1) which mediates most of the known physiological activities of AII....
3.
Langtry H, Gillis J, Davis R
Drugs
. 1997 Nov;
54(5):752-73.
PMID: 9360061
Topiramate is a sulphamate-substituted monosaccharide derived from D-fructose and is structurally unrelated to other antiepileptic drugs. It acts by multiple mechanisms that suggest it may be effective in several types...
4.
Gillis J, Noble S, Goa K
Drugs
. 1997 Apr;
53(4):681-99.
PMID: 9098666
Octreotide is a somatostatin analogue: a long-acting release (LAR) formulation of octreotide is designed for once-monthly intramuscular administration. As with native somatostatin, octreotide LAR exerts potent inhibitory effects on the...
5.
Gillis J, Brogden R
Drugs
. 1997 Jan;
53(1):139-88.
PMID: 9010653
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) with strong analgesic activity. The analgesic efficacy of ketorolac has been extensively evaluated in the postoperative setting, in both hospital inpatients and outpatients,...
6.
Gillis J, Goa K
Pharmacoeconomics
. 1996 Aug;
10(3):281-310.
PMID: 10163575
Thrombolytic therapy with streptokinase and other agents reduces mortality and is now well accepted as the mainstay of revascularisation options for most patients after an acute myocardial infarction. Streptokinase is...
7.
Gillis J, Wiseman L
Drugs
. 1996 Apr;
51(4):621-38.
PMID: 8706597
Secnidazole is structurally related to the commonly used 5-nitroimidazoles metronidazole and tinidazole. These drugs share a common spectrum of activity against anaerobic micro-organisms and they appear particularly effective in the...
8.
Gillis J, Goa K
Drugs
. 1995 Nov;
50(5):897-923.
PMID: 8586032
Tretinoin (all-trans retinoic acid), a vitamin A derivative, induces cellular differentiation in several haematological precursor cell lines and cells from patients with acute promyelocytic leukaemia. Drug treatment with tretinoin is...
9.
Wagstaff A, Gillis J, Goa K
Drugs
. 1995 Aug;
50(2):289-316.
PMID: 8521760
Alteplase is the product of recombinant DNA technology and is chemically identical to endogenous tissue-type plasminogen activator: Plasminogen is converted to plasmin by alteplase, and fibrinolysis of blood thrombi is...
10.
Gillis J, Benfield P, Goa K
Drugs
. 1995 Jul;
50(1):157-75.
PMID: 7588085
Butorphanol is a synthetic opioid agonist-antagonist analgesic with a pharmacological and therapeutic profile that has been well established since its launch as a parenteral formulation in 1978. The introduction of...